The Veteran's effective date for a 100 percent evaluation for symptomatic multiple myeloma, progressions of solitary bone plasmacytoma is granted as of May 13, 2020.
The deciding factor: The evidence shows that on May 13, 2020, the Veteran's asymptomatic plasmocytoma progressed into symptomatic multiple myeloma, warranting a 100 percent rating effective from that date.
- Claimed conditions
- symptomatic multiple myeloma, progressions of solitary bone plasmacytoma
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 100%
- Decision date
- June 24, 2025
- Citation
- A25054174
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Dismissed
The appeal for permanent and total status for symptomatic multiple myeloma and entitlement to a TDIU is dismissed due to concurrent election prohibition.
- Granted
The Board granted service connection for obstructive sleep apnea, effective from the date of the February 2025 rating decision.
- Remanded (sent back)
The Board remands the claim for a medical examination to determine if the Veteran's current neck strain is related to his in-service activities.
- Remanded (sent back)
The Board remands the claim for a rating in excess of 70 percent for PTSD due to an inadequate medical opinion.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.